MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
about
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma.Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.The Eya phosphatase: Its unique role in cancer.Antagonistic effects of nitric oxide in a glioblastoma photodynamic therapy model:mitigation by BET bromodomain inhibitor JQ1.EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes.Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
P2860
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@en
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@nl
type
label
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@en
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@nl
prefLabel
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@en
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@nl
P2860
P356
P1433
P1476
MYC-Master Regulator of the Cancer Epigenome and Transcriptome.
@en
P2093
Candace J Poole
P2860
P356
10.3390/GENES8050142
P577
2017-05-13T00:00:00Z